The Effect of Dexamethasone Administration Route on Pain and Inflammatory Response in PENG Block for Total Hip Arthroplasty
Key facts
- Who runs it
- Poznan University of Medical Sciences
- Where
- Poland1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- Phase
- Phase 4
- People taking part
- 60 people enrolled
- Started
- 1 Feb 2025
- Ended
- 11 Jul 2025
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- perineural Dexamethasone 4mg
- intravenous Dexamethsone 4mg
- Record updated
- 23 July 2025
Who can take part
- Age
- 65 years to 100 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- patients scheduled for total hip arthroplasty
- patients aged >65 and <100 years
- patients able to provide informed consent
- patients able to reliably report symptoms to the research team
Who cannot take part
- inability to provide first-party consent due to cognitive impairment or a language barrier
- infection at the site of the regional block,
- coagulation disorders,
- history of regular steroid medication
- immunodeficiency,
- American Society of Anesthesiologists (ASA) physical status of IV or higher,
Where is this trial?
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This study aims to evaluate the effect of the dexamethasone administration route (intravenous vs. perineural) on postoperative pain, inflammatory response, and clinical outcomes in patients undergoing total hip arthroplasty (THA) with a pericapsular nerve group (PENG) block. The primary outcome is the intensity of postoperative pain measured using the numerical rating scale (NRS) at rest and during movement. Secondary outcomes include the inflammatory response assessed by neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR), opioid consumption, and patient satisfaction. The findings from this study may contribute to optimizing anesthesia protocols and improving postoperative recovery in patients undergoing THA.
The 2 groups in the trial
- Perineural dexamethasoneExisting treatment, for comparison
PENG block + perineural dexamethasone
Treatment: perineural Dexamethasone 4mg
- Intravenous dexamethasoneExisting treatment, for comparison
PENG block + intravenous dexamethasone
Treatment: intravenous Dexamethsone 4mg
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 23 July 2025